Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Radiology
|
January 31, 2014
Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient
Olivio F Donati, Yousef Mazaheri, Asim Afaq, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2014
Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score
Olivio F Donati, Asim Afaq, Hebert Alberto Vargas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2017
Impact of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management
Asim Afaq, Suliman Alahmed, Shih-Hsin Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 27, 2026
Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteria
Dimitrios Priftakis, Fadilah Aziz, Noora Bin Essa, et al.
Nuclear Medicine Communications
|
February 1, 2018
Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE
Athar Haroon, Asim Afaq, Soujanya Nuthakki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2013
Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice
Khalsa Z Al-Nabhani, Rizwan Syed, Sofia Michopoulou, et al.
The Journal of Urology
|
September 29, 2012
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer
Hebert Alberto Vargas, Oguz Akin, Asim Afaq, et al.
Nuclear Medicine Communications
|
April 28, 2026
18F choline PET/MR to assess clinically significant disease in prostate cancer: correlation with maximum and total cancer core length obtained via template mapping biopsies
Athar Haroon, Ahmad Almuhaideb, Sola Adeleke, et al.
Clinical Nuclear Medicine
|
September 9, 2016
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma
Asim Afaq, Francesco Fraioli, Harbir Sidhu, et al.
Nuclear Medicine Communications
|
May 31, 2019
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging
Asim Afaq, Fergus Gleeson, Andrew Scarsbrook, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Radiology
|
January 31, 2014
Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient
Olivio F Donati, Yousef Mazaheri, Asim Afaq, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2014
Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score
Olivio F Donati, Asim Afaq, Hebert Alberto Vargas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2017
Impact of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management
Asim Afaq, Suliman Alahmed, Shih-Hsin Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 27, 2026
Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteria
Dimitrios Priftakis, Fadilah Aziz, Noora Bin Essa, et al.
Nuclear Medicine Communications
|
February 1, 2018
Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE
Athar Haroon, Asim Afaq, Soujanya Nuthakki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2013
Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice
Khalsa Z Al-Nabhani, Rizwan Syed, Sofia Michopoulou, et al.
The Journal of Urology
|
September 29, 2012
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer
Hebert Alberto Vargas, Oguz Akin, Asim Afaq, et al.
Nuclear Medicine Communications
|
April 28, 2026
18F choline PET/MR to assess clinically significant disease in prostate cancer: correlation with maximum and total cancer core length obtained via template mapping biopsies
Athar Haroon, Ahmad Almuhaideb, Sola Adeleke, et al.
Clinical Nuclear Medicine
|
September 9, 2016
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma
Asim Afaq, Francesco Fraioli, Harbir Sidhu, et al.
Nuclear Medicine Communications
|
May 31, 2019
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging
Asim Afaq, Fergus Gleeson, Andrew Scarsbrook, et al.
Page
of 5